EUCTR2005-001849-42-IT进行中(未招募)不适用
A randomized, double blind, placebo controlled, parallel group study to determine the effect of BXL628 in patients with Chronic Non-Bacterial Prostatitis category III Chronic Pelvic Pain Syndrome, CP/CPPS
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
- 发起方
- BIOXELL SPA
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中(未招募)
1 期
Investigate the safety and efficacy of study drug ABX464 compared with placebo in patients with moderate to severe ulcerative colitis who have failed to other treatments.Moderate to Severe Ulcerative ColitisMedDRA version: 20.1Level: LLTClassification code 10066678Term: Acute ulcerative colitisSystem Organ Class: 100000004856EUCTR2018-003558-26-HUABIVAX232
进行中(未招募)
不适用
A randomized, double blind, placebo controlled, parallel-group study to determine the effect of BXL-628 in post-menopausal women with Overactive Bladder (OAB)EUCTR2004-000609-23-ITBIOXELL SPA
进行中(未招募)
不适用
A randomized, double blind, placebo controlled, parallel group trial for assessing the clinical benefit of Dronedarone 400mg BID on top of standard therapy in patients with permanent atrial fibrillation and additional risk factors - Permanent Atrial fibriLLAtion outcome Study using Dronedarone on top of standard therapy (PALLAS)MedDRA version: 12.1Level: LLTClassification code 10003658Term: Atrial fibrillationAtrial FibrillationEUCTR2010-019791-73-SKSanofi-aventis recherche & développement10,800
已完成
不适用
A clinical study to find The safety and efficacy of Asafin in patients suffering from dyspepsiaCTRI/2018/01/011149Akay Flavours and Aromatics Private Limited60
已完成
Unknown
A study to evaluate the effect of Investigational Product on sleep quality and mood state in healthy adultsCTRI/2023/04/051364Vedic Lifesciences Pvt. Ltd175
